Brazil Company Requests Emergency Authorization To Use India's Covaxin

Brazil Company Requests Emergency Authorization To Use India's Covaxin

March 9, 2021, 7:38 a.m.

SAO PAULO/ Brazilian company Precisa Medicamentos, representing India’s Bharat Biotech, on Monday said it requested that the country’s health regulator, Anvisa, grant emergency authorization to use the Covaxin COVID-19 vaccine.

In addition, it said Covaxin would be trialed in a Phase Three study in Brazil carried out in partnership with Sao Paulo’s Albert Einstein hospital.

More on Health

The Latest

Latest Magazine

VOL. 17, No. 22, June.28,2024 (Ashar-14. 2081) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 17, No. 21, June.14,2024 (Jestha-32. 2081) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 17, No. 20, May.24,2024 (Jestha-11. 2081) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 17, No. 19, May.10,2024 (Baishak,28. 2081) Publisher and Editor: Keshab Prasad Poudel Online Register Number: DOI 584/074-75